Fermín
Sánchez-Guijo Martín
Catedrático de Universidad
Publications (159) Fermín Sánchez-Guijo Martín publications
2024
-
Autonomic dysfunction as manifestation of ICANS: A case report
Medicine (United States), Vol. 103, Núm. 36, pp. e38659
-
Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT)
Cytotherapy, Vol. 26, Núm. 7, pp. 681-685
-
Impact of the kinetics of circulating anti-CD19 CAR-T cells and their populations on the outcome of DLBCL patients
Blood cancer journal
-
Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee
eClinicalMedicine, Vol. 69
-
Treatment of post-allogeneic hematopoietic stem cell transplant cytopenias with sequential doses of multipotent mesenchymal stromal/stem cells
Cytotherapy, Vol. 26, Núm. 8, pp. 806-812
2023
-
Autologous mesenchymal stem cell transplantation for spinal fusion: 10 years follow-up of a phase I/II clinical trial
Stem cell research & therapy, Vol. 14, Núm. 1, pp. 78
-
Autologous mesenchymal stromal cells embedded with Tissucol Duo® for prevention of air leak after anatomical lung resection: results of a prospective phase I/II clinical trial with long-term follow-up
Stem Cell Research and Therapy, Vol. 14, Núm. 1
-
Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE)
Bone Marrow Transplantation, Vol. 58, Núm. 6, pp. 659-666
-
Cell and gene therapy workforce development: the role of the International Society for Cell & Gene Therapy (ISCT) in the creation of a sustainable and skilled workforce in Europe
Cytotherapy, Vol. 25, Núm. 10, pp. 1033-1036
-
Effects of Dietary Supplementation with a Ferulic Acid-Rich Bioactive Component of Wheat Bran in a Murine Model of Graft-Versus-Host Disease
Nutrients, Vol. 15, Núm. 21
-
Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations
Blood
-
Long-Term Results of a Phase I/II Clinical Trial of Autologous Mesenchymal Stem Cell Therapy for Femoral Head Osteonecrosis
Journal of Clinical Medicine, Vol. 12, Núm. 6
-
Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV)
Bone Marrow Transplantation
-
Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single-cell resolution
eLife, Vol. 12
2022
-
A Systems Biology- and Machine Learning-Based Study to Unravel Potential Therapeutic Mechanisms of Midostaurin as a Multitarget Therapy on FLT3-Mutated AML
BioMedInformatics, Vol. 2, Núm. 3, pp. 375-397
-
CT-169 Cytokine Release Syndrome After Peripheral Blood Haploidentical Stem Cell Transplantation With Post-Transplant Cyclophosphamide: Time of Onset Matters
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S437-S438
-
CT-195 Predictive Value of ST2, REG3a, and MAGIC Algorithm in Haploidentical Transplantation With Post-Transplant Cyclophosphamide Outcomes
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S438
-
Comparison of Outcomes after Unrelated Double-Unit Cord Blood and Haploidentical Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia: A Study on Behalf of Eurocord and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Transplantation and Cellular Therapy, Vol. 28, Núm. 10, pp. 710.e1-710.e10
-
Eltrombopag increases the hematopoietic supporting ability of mesenchymal stem/stromal cells
Therapeutic Advances in Hematology, Vol. 13
-
External evaluation of population pharmacokinetic models of imatinib in adults diagnosed with chronic myeloid leukaemia
British Journal of Clinical Pharmacology, Vol. 88, Núm. 4, pp. 1913-1924